Deutsche Biotech Innovativ AG Stock BOERSE DUESSELDORF
Equities
VUAG
DE000A0Z25L1
Biotechnology & Medical Research
End-of-day quote
Other stock markets
|
||
- EUR | - |
Sales 2021 | - | Sales 2022 | - | Capitalization | 25.39M 27.15M |
---|---|---|---|---|---|
Net income 2021 | - 0 | Net income 2022 | - 0 | EV / Sales 2021 | - |
Net cash position 2021 | 18.92K 20.24K | Net cash position 2022 | 8.08K 8.64K | EV / Sales 2022 | - |
P/E ratio 2021 |
-371
x | P/E ratio 2022 |
-107
x | Employees | - |
Yield 2021 * |
-
| Yield 2022 |
-
| Free-Float | 99% |
Managers | Title | Age | Since |
---|---|---|---|
Bernd Wegener
CEO | Chief Executive Officer | 76 | 08-12-31 |
Metod Miklus
COO | Chief Operating Officer | 65 | 19-10-06 |
Members of the board | Title | Age | Since |
---|---|---|---|
Bernd Wegener
CEO | Chief Executive Officer | 76 | 08-12-31 |
Metod Miklus
COO | Chief Operating Officer | 65 | 19-10-06 |
Renke Lührs
CHM | Chairman | 64 | 11-02-14 |
1st Jan change | Capi. | |
---|---|---|
+1.99% | 42.59B | |
+8.52% | 40.65B | |
+49.22% | 40.57B | |
-12.36% | 26.77B | |
+9.11% | 24.81B | |
-24.12% | 18.17B | |
+29.25% | 12.05B | |
-2.74% | 11.7B | |
+7.07% | 11.1B |
- Stock Market
- Equities
- DBI Stock
- VUAG Stock